Shows
Growth + ExitBuilding Resilient Health StartupsDanguole Altman is the President and CEO of Cx Precision Medicine, which develops AI-driven tests to improve the diagnosis and treatment of neurodegenerative diseases. She is also a Partner at Newport LLC. With experience founding, leading, and growing innovative life science and healthcare services companies, Danguole founded Vapogenix, a non-opioid pain therapeutics firm, and co-founded FemPartners, a women’s healthcare services company. In this episode… Early diagnosis of degenerative diseases like Alzheimer’s is critical for effective treatment. Yet, primary care physicians often lack clear, efficient tools to assess cognitive decline, leaving patients and families in lim...2025-05-2837 min
StartUp Health NOW PodcastEarly Detection, Better Outcomes: Transforming Alzheimer’s Diagnosis with CxPMImagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer's research and therapies emerge, making early detection more vital than ever.
That’s where Cx Precision Medicine comes in.
In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer's Moonshot Community working to revolutionize early cognit...2025-03-0700 min